Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Donnell MR[au]:

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. O'Donnell MR et al. J Natl Compr Canc Netw. (2017)

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Greenberg PL et al. J Natl Compr Canc Netw. (2017)

Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients. Sala Torra O et al. Biol Blood Marrow Transplant. (2017)

Search results

Items: 1 to 50 of 141

1.

Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection.

O'Donnell MR, Padayatchi N, Daftary A, Orrell C, Dooley KE, Rivet Amico K, Friedland G.

Lancet HIV. 2019 Mar;6(3):e201-e204. doi: 10.1016/S2352-3018(19)30035-9.

PMID:
30846058
2.

Early detection of emergent extensively drug resistant tuberculosis (XDR-TB) by flow cytometry-based phenotyping and whole genome sequencing.

O'Donnell MR, Larsen MH, Brown TS, Jain P, Munsamy V, Wolf A, Uccellini L, Karim F, D'Olivera T, Mathema B, Jacobs WR, Pym A.

Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01834-18. doi: 10.1128/AAC.01834-18. [Epub ahead of print]

PMID:
30670422
3.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D.

Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Review.

PMID:
30215381
4.

Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.

Yuengling KA, Padayatchi N, Wolf A, Mathema B, Brown T, Horsburgh CR, OʼDonnell MR.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):474-480. doi: 10.1097/QAI.0000000000001833.

PMID:
30212394
5.

Precision surveillance for viral respiratory pathogens: virome capture sequencing for the detection and genomic characterization of severe acute respiratory infection in Uganda.

Cummings MJ, Tokarz R, Bakamutumaho B, Kayiwa J, Byaruhanga T, Owor N, Namagambo B, Wolf A, Mathema B, Lutwama JJ, Schluger NW, Lipkin WI, O'Donnell MR.

Clin Infect Dis. 2018 Aug 7. doi: 10.1093/cid/ciy656. [Epub ahead of print]

PMID:
30099510
6.

Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.

Bionghi N, Daftary A, Maharaj B, Msibi Z, Amico KR, Friedland G, Orrell C, Padayatchi N, O'Donnell MR.

BMC Infect Dis. 2018 Apr 11;18(1):171. doi: 10.1186/s12879-018-3080-2.

7.

Training social workers to enhance patient-centered care for drug-resistant TB-HIV in South Africa.

Zelnick JR, Seepamore B, Daftary A, Amico KR, Bhengu X, Friedland G, Padayatchi N, Naidoo K, O'Donnell MR.

Public Health Action. 2018 Mar 21;8(1):25-27. doi: 10.5588/pha.17.0114.

8.

Transmission dynamics of influenza in two major cities of Uganda.

Yang W, Cummings MJ, Bakamutumaho B, Kayiwa J, Owor N, Namagambo B, Byaruhanga T, Lutwama JJ, O'Donnell MR, Shaman J.

Epidemics. 2018 Sep;24:43-48. doi: 10.1016/j.epidem.2018.03.002. Epub 2018 Mar 19.

9.

Dynamics of influenza in tropical Africa: Temperature, humidity, and co-circulating (sub)types.

Yang W, Cummings MJ, Bakamutumaho B, Kayiwa J, Owor N, Namagambo B, Byaruhanga T, Lutwama JJ, O'Donnell MR, Shaman J.

Influenza Other Respir Viruses. 2018 Jul;12(4):446-456. doi: 10.1111/irv.12556. Epub 2018 Apr 17.

10.

Emergence, Epidemiology, and Transmission Dynamics of 2009 Pandemic A/H1N1 Influenza in Kampala, Uganda, 2009-2015.

Cummings MJ, Bakamutumaho B, Yang W, Wamala JF, Kayiwa J, Owor N, Namagambo B, Byaruhanga T, Wolf A, Lutwama JJ, Shaman J, O'Donnell MR.

Am J Trop Med Hyg. 2018 Jan;98(1):203-206. doi: 10.4269/ajtmh.17-0524. Epub 2018 Jan 1.

11.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.

Aldoss I, Pham A, Li SM, Gendzekhadze K, Afkhami M, Telatar M, Hong H, Padeganeh A, Bedell V, Cao T, Khaled SK, Malki MMA, Salhotra A, Ali H, Aribi A, Palmer J, Aoun P, Spielberger R, Stein AS, Snyder D, O'Donnell MR, Murata-Collins J, Senitzer D, Weisenburger D, Forman SJ, Pullarkat V, Marcucci G, Pillai R, Nakamura R.

Haematologica. 2017 Dec;102(12):2030-2038. doi: 10.3324/haematol.2017.172544. Epub 2017 Sep 29.

12.

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Bhatt V, Bixby D, Blum W, Coutre SE, De Lima M, Fathi AT, Fiorella M, Foran JM, Gore SD, Hall AC, Kropf P, Lancet J, Maness LJ, Marcucci G, Martin MG, Moore JO, Olin R, Peker D, Pollyea DA, Pratz K, Ravandi F, Shami PJ, Stone RM, Strickland SA, Wang ES, Wieduwilt M, Gregory K, Ogba N.

J Natl Compr Canc Netw. 2017 Jul;15(7):926-957. doi: 10.6004/jnccn.2017.0116.

PMID:
28687581
13.

Elucidating the role of clofazimine for the treatment of tuberculosis.

O'Donnell MR, Padayatchi N, Metcalfe JZ.

Int J Tuberc Lung Dis. 2016 Dec 1;20(12):52-57. doi: 10.5588/ijtld.16.0073. Review.

PMID:
28240574
14.

Turning the tide against tuberculosis.

Padayatchi N, Naidu N, Friedland G, Naidoo K, Conradie F, Naidoo K, O'Donnell MR.

Int J Infect Dis. 2017 Mar;56:6-9. doi: 10.1016/j.ijid.2017.01.012. Epub 2017 Feb 4.

15.

Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.

Sala Torra O, Othus M, Williamson DW, Wood B, Kirsch I, Robins H, Beppu L, O'Donnell MR, Forman SJ, Appelbaum FR, Radich JP.

Biol Blood Marrow Transplant. 2017 Apr;23(4):691-696. doi: 10.1016/j.bbmt.2016.12.639. Epub 2017 Jan 3.

16.

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Greenberg PL, Stone RM, Al-Kali A, Barta SK, Bejar R, Bennett JM, Carraway H, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Horsfall R, Johnson RA, Juckett M, Klimek VM, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Shami PJ, Stein BL, Walker AR, Westervelt P, Zeidan A, Shead DA, Smith C.

J Natl Compr Canc Netw. 2017 Jan;15(1):60-87.

PMID:
28040720
17.

Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.

Zelnick JR, O'Donnell MR, Ahuja SD, Chua A, Sullivan Meissner J.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1625-1632.

PMID:
27931338
18.

Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum.

Jain P, Weinrick BC, Kalivoda EJ, Yang H, Munsamy V, Vilcheze C, Weisbrod TR, Larsen MH, O'Donnell MR, Pym A, Jacobs WR Jr.

MBio. 2016 Oct 25;7(5). pii: e01023-16. doi: 10.1128/mBio.01023-16.

19.

Epidemiologic and Spatiotemporal Characterization of Influenza and Severe Acute Respiratory Infection in Uganda, 2010-2015.

Cummings MJ, Bakamutumaho B, Kayiwa J, Byaruhanga T, Owor N, Namagambo B, Wolf A, Wamala JF, Morse SS, Lutwama JJ, O'Donnell MR.

Ann Am Thorac Soc. 2016 Dec;13(12):2159-2168.

20.

Allogeneic Hematopoietic Cell Transplantation for AML-A Missed Opportunity!

O'Donnell MR.

J Natl Compr Canc Netw. 2016 Sep;14(9):1052-3. No abstract available.

PMID:
27587618
21.

Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis.

Padayatchi N, Naidu N, Yende-Zuma N, OʼDonnell MR, Naidoo K, Augustine S, Zumla A, Loveday M.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):e1-7. doi: 10.1097/QAI.0000000000001110.

PMID:
27509173
22.

Unfinished business: severe acute respiratory infection in sub-Saharan Africa.

Cummings MJ, Bakamutumaho B, O'Donnell MR.

Intensive Care Med. 2016 Sep;42(9):1515-6. doi: 10.1007/s00134-016-4383-7. Epub 2016 May 12. No abstract available.

PMID:
27172822
23.

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.

Desjardins CA, Cohen KA, Munsamy V, Abeel T, Maharaj K, Walker BJ, Shea TP, Almeida DV, Manson AL, Salazar A, Padayatchi N, O'Donnell MR, Mlisana KP, Wortman J, Birren BW, Grosset J, Earl AM, Pym AS.

Nat Genet. 2016 May;48(5):544-51. doi: 10.1038/ng.3548. Epub 2016 Apr 11.

24.

Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.

O'Donnell MR, Daftary A, Frick M, Hirsch-Moverman Y, Amico KR, Senthilingam M, Wolf A, Metcalfe JZ, Isaakidis P, Davis JL, Zelnick JR, Brust JC, Naidu N, Garretson M, Bangsberg DR, Padayatchi N, Friedland G.

Int J Tuberc Lung Dis. 2016 Apr;20(4):430-4. doi: 10.5588/ijtld.15.0360.

25.

In reply.

Cummings MJ, O'Donnell MR.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1559. doi: 10.5588/ijtld.15.0837-2. No abstract available.

PMID:
26614207
26.

Inverting the pyramid: increasing awareness of mycobacterial sepsis in sub-Saharan Africa.

Cummings MJ, O'Donnell MR.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1128-34. doi: 10.5588/ijtld.14.0967.

27.

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.

Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Pym AS, Earl AM.

PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.

28.

Moving Beyond Directly Observed Therapy for Tuberculosis.

Metcalfe JZ, O'Donnell MR, Bangsberg DR.

PLoS Med. 2015 Sep 15;12(9):e1001877. doi: 10.1371/journal.pmed.1001877. eCollection 2015 Sep. No abstract available.

29.

A Novel Reporter Phage To Detect Tuberculosis and Rifampin Resistance in a High-HIV-Burden Population.

O'Donnell MR, Pym A, Jain P, Munsamy V, Wolf A, Karim F, Jacobs WR Jr, Larsen MH.

J Clin Microbiol. 2015 Jul;53(7):2188-94. doi: 10.1128/JCM.03530-14. Epub 2015 Apr 29.

30.

Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.

OʼDonnell MR, Pillay M, Pillay M, Werner L, Master I, Wolf A, Mathema B, Coovadia YM, Mlisana K, Horsburgh CR, Padayatchi N.

J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):536-43. doi: 10.1097/QAI.0000000000000650.

31.

Myelodysplastic syndromes, version 2.2015.

Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Klimek V, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Scott B, Shami PJ, Stein BL, Westervelt P, Wheeler B, Shead DA, Smith C; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Mar;13(3):261-72.

32.

Survival following lung resection in immunocompromised patients with pulmonary invasive fungal infection.

Wu GX, Khojabekyan M, Wang J, Tegtmeier BR, O'Donnell MR, Kim JY, Grannis FW, Raz DJ.

Eur J Cardiothorac Surg. 2016 Jan;49(1):314-20. doi: 10.1093/ejcts/ezv026. Epub 2015 Mar 1.

33.

Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.

Hicks RM, Padayatchi N, Shah NS, Wolf A, Werner L, Sunkari VB, O'Donnell MR.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1074-83. doi: 10.5588/ijtld.14.0231.

PMID:
25189555
34.

FAT1 cadherin is multiply phosphorylated on its ectodomain but phosphorylation is not catalysed by the four-jointed homologue.

Sadeqzadeh E, de Bock CE, O'Donnell MR, Timofeeva A, Burns GF, Thorne RF.

FEBS Lett. 2014 Sep 17;588(18):3511-7. doi: 10.1016/j.febslet.2014.08.014. Epub 2014 Aug 19.

35.

Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.

Padayatchi N, Gopal M, Naidoo R, Werner L, Naidoo K, Master I, O'Donnell MR.

J Antimicrob Chemother. 2014 Nov;69(11):3103-7. doi: 10.1093/jac/dku235. Epub 2014 Jun 30.

36.

Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.

OʼDonnell MR, Wolf A, Werner L, Horsburgh CR, Padayatchi N.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):22-9. doi: 10.1097/QAI.0000000000000221.

37.

Long walk to treatment for XDR tuberculosis in South Africa.

O'Donnell MR, Schluger NW.

Lancet. 2014 Apr 5;383(9924):1193-4. doi: 10.1016/S0140-6736(14)60043-X. Epub 2014 Jan 17. No abstract available.

PMID:
24439236
38.

Acute myeloid leukemia, version 2.2013.

O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Lancet J, Maness LJ, Marcucci G, Martin MG, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Wang ES, Gregory KM, Naganuma M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Sep 1;11(9):1047-55.

39.

Myelodysplastic syndromes: clinical practice guidelines in oncology.

Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, Frankfurt O, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, O'Donnell MR, Shami PJ, Stein BL, Stone RM, Thompson JE, Westervelt P, Wheeler B, Shead DA, Naganuma M.

J Natl Compr Canc Netw. 2013 Jul;11(7):838-74.

40.

Risk stratification and emerging treatment strategies in acute myeloid leukemia.

O'Donnell MR.

J Natl Compr Canc Netw. 2013 May;11(5 Suppl):667-9. Review.

PMID:
23704239
41.

Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV setting.

Zelnick JR, Gibbs A, Loveday M, Padayatchi N, O'Donnell MR.

J Public Health Policy. 2013 Aug;34(3):388-402. doi: 10.1057/jphp.2013.20. Epub 2013 May 30.

42.

Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.

O'Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Horsburgh CR Jr.

Emerg Infect Dis. 2013 Mar;19(3):416-24. doi: 10.3201/eid1903.120998.

43.

Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

Gopal M, Padayatchi N, Metcalfe JZ, O'Donnell MR.

Int J Tuberc Lung Dis. 2013 Aug;17(8):1001-7. doi: 10.5588/ijtld.12.0144. Epub 2013 Mar 25. Review.

44.

NCCN Clinical Practice Guidelines Acute myeloid leukemia.

O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Goorha S, Lancet J, Maness LJ, Marcucci G, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES, Naganuma M, Gregory KM.

J Natl Compr Canc Netw. 2012 Aug;10(8):984-1021.

PMID:
22878824
45.

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis.

Nakamura R, Palmer JM, O'Donnell MR, Stiller T, Thomas SH, Chao J, Alvarnas J, Parker PM, Pullarkat V, Maegawa R, Stein AS, Snyder DS, Bhatia R, Chang K, Wang S, Cai JL, Senitzer D, Forman SJ.

Leuk Res. 2012 Sep;36(9):1152-6. doi: 10.1016/j.leukres.2012.04.022. Epub 2012 Jun 5.

46.

Sustained reduction in tuberculosis incidence following a community-based participatory intervention.

O'Donnell MR, Chamblee S, von Reyn CF, Marsh BJ, Moreland JD, Narita M, Johnson LS, Horsburgh CR Jr.

Public Health Action. 2012 Mar 21;2(1):23-6. doi: 10.5588/pha.11.0023.

47.

Acceptance of interferon-gamma release assay by a high-risk urban cohort.

O'Donnell MR, Coe A, Bliss C, Lee D, Tumilty S, Skolnik PR, Horsburgh CR Jr, Cotton D, Saukkonen J.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1334-9. doi: 10.5588/ijtld.11.0029.

PMID:
22283891
48.

φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.

Jain P, Hartman TE, Eisenberg N, O'Donnell MR, Kriakov J, Govender K, Makume M, Thaler DS, Hatfull GF, Sturm AW, Larsen MH, Moodley P, Jacobs WR Jr.

J Clin Microbiol. 2012 Apr;50(4):1362-9. doi: 10.1128/JCM.06192-11. Epub 2012 Jan 25.

49.

Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa.

O'Donnell MR, Zelnick J, Werner L, Master I, Loveday M, Horsburgh CR, Padayatchi N.

Emerg Infect Dis. 2011 Oct;17(10):1942-5. doi: 10.3201/eid1710.110105.

50.

Spherical indentation of free-standing acellular extracellular matrix membranes.

Cloonan AJ, O'Donnell MR, Lee WT, Walsh MT, De Barra E, McGloughlin TM.

Acta Biomater. 2012 Jan;8(1):262-73. doi: 10.1016/j.actbio.2011.08.003. Epub 2011 Aug 12.

PMID:
21864728

Supplemental Content

Loading ...
Support Center